Clinical Trial Results:
Abatacept in patients with Birdshot HLA A29 uveitis: A Phase II
Prospective 0pen Label Interventional Proof-of-Concept Study
Summary
|
|
EudraCT number |
2018-003653-16 |
Trial protocol |
BE |
Global completion date |
24 Oct 2023
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Nov 2024
|
First version publication date |
06 Nov 2024
|
Other versions |
|
Summary report(s) |
study results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.